The Food and Drug Administration approved the drug, called Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. It's taken once a day for 14 days.
FDA approves first oral treatment for postpartum depression - Pharmaceutical Technology
Fda Approves First Postpartum Depression Pill Stock Photo
FDA approves first postpartum depression pill in the US
FDA Approves First Pill for Postpartum Depression - The New York Times
FDA approves pill to treat postpartum depression, Lifestyles
Zuranolone FDA approval adds treatment option for women with
Zuranolone: First FDA-Approved Pill for Postpartum Depression
FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral
FDA approves first postpartum depression pill - The Standard Health
FDA For The Baby Blues: First Pill for Postpartum Depression - Fortunes Crown
FDA approves first postpartum depression pill
Insight: FDA approves first postpartum depression pill in U.S. – KXAN Austin
FDA approves first postpartum depression pill in the US